Guidant Bid War Sure Sign of Medical Device Sector Boom
The New York Times explains how the bid war between J&J and Boston Scientific to buy troubled Guidant (Boston Scientific just upped its bid to $27B) illustrates the increasing attractiveness of the medical device sector, as compared to the economy as a whole and to other health-related activities such as drug manufacturing specifically. With the […]